Fig. 5From: The additional value of 18F-FDG PET/CT imaging in guiding the treatment strategy of non-tuberculous mycobacterial patientsSpearman’s rank analysis of 18F-FDG uptake (SUVSpleen and SUVMarrow) and laboratory markers such as interleukin 6 (IL-6), procalcitonin (PCT) and ferritinBack to article page